| Typicality: | 0.568 |
| Saliency: | 0.366 |
| randomly | 38 | manner |
| to receive either an experimental treatment | 5 | purpose |
| in each cohort | 4 | location |
| subject → be assigned to receive → placebo | 23 |
| subject → be assigned to → placebo | 18 |
| subject → be assigned → placebo | 6 |
| subject → be assigned to → the placebo | 3 |
| negative | neutral | positive |
| 0.141 | 0.815 | 0.044 |
| Raw frequency | 50 |
| Normalized frequency | 0.366 |
| Modifier score | 1.000 |
| Perplexity | 46.874 |